Patent US5068983A successfully refreshed from Google Patents.
Patent US5735897A successfully refreshed from Google Patents.
US5735897A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Intravascular stent pump
Assignee: Boston Scientific Scimed Inc
•
Filing: 1997-01-02
•
Granted: 1998-04-07
•
Expires: 2017-01-02
Abstract
Abstract A multi-layer vascular therapeutic-containing prosthesis designed and arranged to "pump" the therapeutics into the blood stream.
Inventors
- 👤 Andrew W. Buirge
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:09
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61M; A61M29/00; A61M29/02; A61F2/0077; A61F2250/00; A61F2250/0058; A61F2250/0067
Claims Analysis
Total Claims: 72
Claim 1
Independent Claim
113 words
An implantable device constructed and arranged in a laminate structure comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer of a matrix material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, wherein said device upon implantation has a predetermined outer diameter selected to correspond substantially with an inner diameter of an implant site, whereby when the device is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable matrix material.
Claim 2
Dependent Claim
113 words
An implantable device constructed and arranged in a laminate structure comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer of a matrix material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, wherein said device upon implantation has a predetermined outer diameter selected to correspond substantially with an inner diameter of an implant site, whereby when the device is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable matrix material.
Claim 3
Dependent Claim
16 words
The device of claim 1 wherein the first and second layers are comprised of polymeric material.
Claim 4
Dependent Claim
27 words
The device of claim 2 wherein the polymeric material is selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof.
Claim 5
Dependent Claim
10 words
The device of claim 1 in a cylindrical, stent-like configuration.
Claim 6
Dependent Claim
20 words
The device of claim 1 wherein at least one of the first and second layers is comprised of polymeric material.
Claim 7
Dependent Claim
48 words
The device of claim 1 wherein the intermediate layer is made of a material selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide or polyvinyl alcohol, said intermediate layer being made up in an aqueous solution containing the dissolved drug or therapeutic to be contained therein.
Claim 8
Dependent Claim
39 words
A device as in claim 1 wherein the first and second spaced layers are each comprised of a curable and resorbable material and the intermediate third layer and the drug or therapeutic contained in the intermediate layer are resorbable.
Claim 9
Dependent Claim
93 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate matrix layer of blood-swellable material, the matrix layer containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable matrix material, said device upon implantation having a predetermined outer diameter selected to correspond substantially with an inner diameter of an implant site.
Claim 10
Dependent Claim
93 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate matrix layer of blood-swellable material, the matrix layer containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable matrix material, said device upon implantation having a predetermined outer diameter selected to correspond substantially with an inner diameter of an implant site.
Claim 11
Dependent Claim
19 words
The device of claim 8 wherein the inner and outer layers of support material are comprised of polymeric material.
Claim 12
Dependent Claim
20 words
The device of claim 8 wherein at least one of the inner and outer layers is comprised of polymeric material.
Claim 13
Dependent Claim
35 words
The device of claim 10 wherein the at least one polymeric layer is made of a polymeric material selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof.
Claim 14
Dependent Claim
41 words
The device of claim 8 wherein the outer layer is comprised of a polymer, a reactive monomer and a polymerization initiator; the intermediate layer is comprised of a swellable drug-bearing layer, and the inner layer is comprised of a porous material.
Claim 15
Dependent Claim
155 words
The device of claim 8 wherein: a) the outer layer is comprised of a polymeric material selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof, a reactive monomer and a polymerization initiator; b) the intermediate layer is comprised of a swellable drug-bearing layer made of a material selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide or polyvinyl alcohol, said intermediate layer being made up in an aqueous solution containing the dissolved drug or therapeutic to be contained therein; and c) the inner layer is a porous polymeric material comprising a polymer selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof, a reactive monomer, a polymerization initiator and a component selected from the group consisting of microcrystalline salts, simple inorganic salts, sugars, polysaccharides or mixtures thereof in an effective amount to impart porosity to said inner layer.
Claim 16
Dependent Claim
27 words
A device as in claim 8 wherein the inner and outer binding layers are curable and resorbable and the intermediate matrix layer containing therapeutic materials is resorbable.
Claim 17
Dependent Claim
109 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: a) an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and additionally including microcrystalline sodium heparin; b) an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone; and c) an intermediate matrix layer of blood-swellable material, the matrix layer containing therapeutic materials to be dispersed into the blood, said intermediate matrix layer being comprised of polyvinylpyrrolidone, water and sodium heparin.
Claim 18
Dependent Claim
109 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: a) an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and additionally including microcrystalline sodium heparin; b) an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone; and c) an intermediate matrix layer of blood-swellable material, the matrix layer containing therapeutic materials to be dispersed into the blood, said intermediate matrix layer being comprised of polyvinylpyrrolidone, water and sodium heparin.
Claim 19
Dependent Claim
131 words
An implantable device constructed and arranged in a laminate structure, the device comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer of a matrix material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, wherein said device has a first outer diameter prior to implantation in a body and a second outer diameter after implantation, and the outer diameter of the device after implantation corresponds substantially with an inner diameter of an implant site, whereby when the device is implanted in a body, the drug or therapeutic is pumped into the implant site in response to the swelling of the fluid-swellable matrix material.
Claim 20
Dependent Claim
131 words
An implantable device constructed and arranged in a laminate structure, the device comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer of a matrix material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, wherein said device has a first outer diameter prior to implantation in a body and a second outer diameter after implantation, and the outer diameter of the device after implantation corresponds substantially with an inner diameter of an implant site, whereby when the device is implanted in a body, the drug or therapeutic is pumped into the implant site in response to the swelling of the fluid-swellable matrix material.
Claim 21
Dependent Claim
110 words
An implantable device having a generally cylindrical form constructed and arranged for fluid flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate matrix layer of fluid-swellable material, the matrix layer containing therapeutic materials to be dispersed into an implant site in a body in response to the swelling of the fluid-swellable matrix material, said device having a first outer diameter prior to implantation, and a second outer diameter after implantation, the outer diameter of the device after implantation corresponds substantially with an inner diameter of the implant site.
Claim 22
Dependent Claim
110 words
An implantable device having a generally cylindrical form constructed and arranged for fluid flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate matrix layer of fluid-swellable material, the matrix layer containing therapeutic materials to be dispersed into an implant site in a body in response to the swelling of the fluid-swellable matrix material, said device having a first outer diameter prior to implantation, and a second outer diameter after implantation, the outer diameter of the device after implantation corresponds substantially with an inner diameter of the implant site.
Claim 23
Dependent Claim
117 words
An implantable device constructed and arranged in a laminate structure, comprising: first and second spaced layers of support material comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, at least one of which is fluid permeable and is further comprised of microcrystalline sodium heparin, an intermediate third of a matrix material having fluid-swellable characteristics, said intermediate layer being comprised of polyvinylpyrrolidone water and sodium heparin, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, whereby when the device is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable matrix material.
Claim 24
Dependent Claim
117 words
An implantable device constructed and arranged in a laminate structure, comprising: first and second spaced layers of support material comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, at least one of which is fluid permeable and is further comprised of microcrystalline sodium heparin, an intermediate third of a matrix material having fluid-swellable characteristics, said intermediate layer being comprised of polyvinylpyrrolidone water and sodium heparin, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, whereby when the device is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable matrix material.
Claim 25
Dependent Claim
111 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate, 2-hydroxy-2-methyl-1-phenyl-1-propanone, and microcrystalline sodium heparin; an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1propanone, and an intermediate matrix layer of blood-swellable material, the matrix layer being comprised of polyvinylpyrrolidone, water and sodium heparin and further containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable matrix material.
Claim 26
Dependent Claim
111 words
An implantable intravascular device having a generally cylindrical form constructed and arranged for blood flow therethrough, said device comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate, 2-hydroxy-2-methyl-1-phenyl-1-propanone, and microcrystalline sodium heparin; an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1propanone, and an intermediate matrix layer of blood-swellable material, the matrix layer being comprised of polyvinylpyrrolidone, water and sodium heparin and further containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable matrix material.
Claim 27
Dependent Claim
118 words
An implantable stent comprising: a) first and second spaced layers of support material, at least one of said layers being fluid permeable; b) an intermediate third layer of a material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, said first, second and third layers being constructed and arranged in a laminate structure; and c) a drug or therapeutic contained in the intermediate layer, wherein said stent upon implantation has an outer diameter adapted to fit an inner diameter of an implant site, whereby when the stent is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable material.
Claim 28
Dependent Claim
118 words
An implantable stent comprising: a) first and second spaced layers of support material, at least one of said layers being fluid permeable; b) an intermediate third layer of a material having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, said first, second and third layers being constructed and arranged in a laminate structure; and c) a drug or therapeutic contained in the intermediate layer, wherein said stent upon implantation has an outer diameter adapted to fit an inner diameter of an implant site, whereby when the stent is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable material.
Claim 29
Dependent Claim
16 words
The implantable stent of claim 20 adapted to be expanded in situ to fit the vessel.
Claim 30
Dependent Claim
12 words
The implantable stent of claim 21 wherein the stent is balloon expandable.
Claim 31
Dependent Claim
11 words
The implantable stent of claim 21 wherein the stent is self-expanding.
Claim 32
Dependent Claim
21 words
The implantable stent of claim 20 wherein at least one of the first and second layers is comprised of polymeric material.
Claim 33
Dependent Claim
17 words
The implantable stent of claim 24 wherein the first and second layers are comprised of polymeric material.
Claim 34
Dependent Claim
28 words
The implantable stent of claim 24 wherein the polymeric material is selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides, and mixtures thereof.
Claim 35
Dependent Claim
49 words
The implantable stem of claim 20 wherein the intermediate layer is made of a material selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide or polyvinyl alcohol, said intermediate layer being made up in an aqueous solution containing the dissolved drug or therapeutic to be contained therein.
Claim 36
Dependent Claim
39 words
A implantable stent of claim 26 wherein the first and second spaced layers are each comprised of a curable and resorbable material and the intermediate third layer and the drug or therapeutic contained in the intermediate layer are resorbable.
Claim 37
Dependent Claim
86 words
An implantable intravascular stent having a generally cylindrical form adapted for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate layer of blood-swellable material, the intermediate layer containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable material, said stent upon implantation having an outer diameter adapted to fit an inner diameter of an implant site.
Claim 38
Dependent Claim
86 words
An implantable intravascular stent having a generally cylindrical form adapted for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate layer of blood-swellable material, the intermediate layer containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable material, said stent upon implantation having an outer diameter adapted to fit an inner diameter of an implant site.
Claim 39
Dependent Claim
14 words
The stent of claim 29 adapted to be expanded to fit the implant site.
Claim 40
Dependent Claim
9 words
The stent of claim 30 which is balloon expandable.
Claim 41
Dependent Claim
8 words
The stent of claim 30 which is self-expanding.
Claim 42
Dependent Claim
19 words
The stent of claim 29 wherein the inner and outer layers of support material are comprised of polymeric material.
Claim 43
Dependent Claim
20 words
The stent of claim 29 wherein at least one of the inner and outer layers is comprised of polymeric material.
Claim 44
Dependent Claim
35 words
The stent of claim 34 wherein the at least one polymeric layer is made of a polymeric material selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof.
Claim 45
Dependent Claim
155 words
The stent of claim 29 wherein: a) the outer layer is comprised of a polymeric material selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof, a reactive monomer and a polymerization initiator; b) the intermediate layer is comprised of a swellable drug-bearing layer made of a material selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene oxide or polyvinyl alcohol, said intermediate layer being made up in an aqueous solution containing the dissolved drug or therapeutic to be contained therein; and c) the inner layer is a porous polymeric material comprising a polymer selected from the group consisting of polylactics, polyacetates, polyacrylates, polyglycol, polycaprolactones, polyesters, polyethers, polyamides and mixtures thereof, a reactive monomer, a polymerization initiator and a component selected from the group consisting of microcrystalline salts, simple inorganic salts, sugars, polysaccharides or mixtures thereof in an effective amount to impart porosity to said inner layer.
Claim 46
Dependent Claim
27 words
A stent as in claim 29 wherein the inner and outer binding layers are curable and resorbable and the intermediate matrix layer containing therapeutic materials is resorbable.
Claim 47
Dependent Claim
41 words
The stent of claim 29 wherein the outer layer is comprised of a polymer, a reactive monomer and a polymerization initiator; the intermediate layer is comprised of a swellable drug-bearing layer, and the inner layer is comprised of a porous material.
Claim 48
Dependent Claim
107 words
An implantable intravascular stent having a generally cylindrical form constructed and arranged for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: a) an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and additionally including microcrystalline sodium heparin; b) an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone; and c) an intermediate layer of blood-swellable material, the intermediate layer containing therapeutic materials to be dispersed into the blood, said intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin.
Claim 49
Dependent Claim
107 words
An implantable intravascular stent having a generally cylindrical form constructed and arranged for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: a) an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and additionally including microcrystalline sodium heparin; b) an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone; and c) an intermediate layer of blood-swellable material, the intermediate layer containing therapeutic materials to be dispersed into the blood, said intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin.
Claim 50
Dependent Claim
14 words
The stent of claim 39 adapted to be expanded to fit the implant site.
Claim 51
Dependent Claim
10 words
The stent of claim 40, said stent being balloon expandable.
Claim 52
Dependent Claim
9 words
The stent of claim 40, said stent being self-expanding.
Claim 53
Dependent Claim
120 words
An implantable stent comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate third layer, wherein said stent has a first outer diameter prior to implantation in a body and a second outer diameter after implantation, and the outer diameter of the stent after implantation corresponds substantially with an inner diameter of an implant site, whereby when the stent is implanted in a body, the drug or therapeutic is pumped into the implant site in response to the swelling of the fluid-swellable intermediate third layer.
Claim 54
Dependent Claim
120 words
An implantable stent comprising: first and second spaced layers of support material, at least one of said layers being fluid permeable, an intermediate third layer having fluid-swellable characteristics, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate third layer, wherein said stent has a first outer diameter prior to implantation in a body and a second outer diameter after implantation, and the outer diameter of the stent after implantation corresponds substantially with an inner diameter of an implant site, whereby when the stent is implanted in a body, the drug or therapeutic is pumped into the implant site in response to the swelling of the fluid-swellable intermediate third layer.
Claim 55
Dependent Claim
14 words
The stent of claim 43 adapted to be expanded to fit the implant site.
Claim 56
Dependent Claim
9 words
The stent of claim 44 which is balloon expandable.
Claim 57
Dependent Claim
8 words
The stent of claim 45 which is self-expanding.
Claim 58
Dependent Claim
109 words
An implantable stent having a generally cylindrical form and being adapted for fluid flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate layer of fluid-swellable material, the intermediate layer containing therapeutic materials to be dispersed into an implant site in a body in response to the swelling of the fluid-swellable material, said stent having a first outer diameter prior to implantation, and a second outer diameter after implantation, wherein the outer diameter of the stent after implantation corresponds substantially with an inner diameter of the implant site.
Claim 59
Dependent Claim
109 words
An implantable stent having a generally cylindrical form and being adapted for fluid flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material; an outer binding layer of support material, and an intermediate layer of fluid-swellable material, the intermediate layer containing therapeutic materials to be dispersed into an implant site in a body in response to the swelling of the fluid-swellable material, said stent having a first outer diameter prior to implantation, and a second outer diameter after implantation, wherein the outer diameter of the stent after implantation corresponds substantially with an inner diameter of the implant site.
Claim 60
Dependent Claim
14 words
The stent of claim 47 adapted to be expanded to fit the implant site.
Claim 61
Dependent Claim
9 words
The stent of claim 48 which is balloon expandable.
Claim 62
Dependent Claim
8 words
The stent of claim 48 which is self-expanding.
Claim 63
Dependent Claim
106 words
An implantable stent comprising: first and second spaced layers of support material comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, at least one of which is fluid permeable and is further comprised of microcrystalline sodium heparin, an intermediate third layer having fluid-swellable characteristics, said intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, whereby when the stent is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable material.
Claim 64
Dependent Claim
106 words
An implantable stent comprising: first and second spaced layers of support material comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, at least one of which is fluid permeable and is further comprised of microcrystalline sodium heparin, an intermediate third layer having fluid-swellable characteristics, said intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin, the intermediate layer being held between the first and second layers, and a drug or therapeutic contained in the intermediate layer, whereby when the stent is implanted in a vessel in a body, the drug or therapeutic is pumped into the vessel in response to the swelling of the fluid-swellable material.
Claim 65
Dependent Claim
14 words
The stent of claim 51 adapted to be expanded to fit the implant site.
Claim 66
Dependent Claim
9 words
The stent of claim 52 which is balloon expandable.
Claim 67
Dependent Claim
8 words
The stent of claim 52 which is self-expanding.
Claim 68
Dependent Claim
107 words
An implantable intravascular stent having a generally cylindrical form adapted for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate, 2-hydroxy-2-methyl-1-phenyl-1-propanone, and microcrystalline sodium heparin; an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and an intermediate layer of blood-swellable material, the intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin and further containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable material.
Claim 69
Dependent Claim
107 words
An implantable intravascular stent having a generally cylindrical form adapted for blood flow therethrough, said stent comprising a multi-layer wall, said wall comprising at least: an inner binding layer of permeable support material, said inner layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate, 2-hydroxy-2-methyl-1-phenyl-1-propanone, and microcrystalline sodium heparin; an outer binding layer of support material, said outer layer being comprised of poly-D,L-lactic acid, ethylene glycol dimethacrylate and 2-hydroxy-2-methyl-1-phenyl-1-propanone, and an intermediate layer of blood-swellable material, the intermediate layer being comprised of polyvinylpyrrolidone, water and sodium heparin and further containing therapeutic materials to be dispersed into the blood in response to the swelling of the blood-swellable material.
Claim 70
Dependent Claim
14 words
The stent of claim 55 adapted to be expanded to fit the implant site.
Claim 71
Dependent Claim
9 words
The stent of claim 56 which is balloon expandable.
Claim 72
Dependent Claim
8 words
The stent of claim 56 which is self-expanding.
References Cited (Backward Citations)
US3056408A
Cited
US4900303A
Cited
US4219520A
Cited
US4230119A
Cited
US4404971A
Cited
US4520823A
Cited
US4902289A
Cited
US4503569A
Cited
US4929240A
Cited
EP0157178A1
Cited
JPS60190966A
Cited
US4879135A
Cited
US4763653A
Cited
US4806595A
Cited
US4923464A
Cited
US4776337B1
Cited
US5102417A
Cited
US4776337A
Cited
US4922905A
Cited
US5061281A
Cited
US5028597A
Cited
US4832688A
Cited
DE3627487A1
Cited
US4840690A
Cited
JPS6397158A
Cited
US5041126A
Cited
US5037427A
Cited
US5059211A
Cited
US4795458A
Cited
US4969890A
Cited
US5089005A
Cited
US4886062A
Cited
US4820298A
Cited
US4877030A
Cited
US4830003A
Cited
US5092877A
Cited
US5019090A
Cited
US5085629A
Cited
US4950227A
Cited
US5207705A
Cited
EP0382158A1
Cited
US5100429A
Cited
US5015253A
Cited
US5104403A
Cited
US5201778A
Cited
US5092839A
Cited
US5413572A
Cited
US5078736A
Cited
US5092841A
Cited
US5057321A
Cited
US5116360A
Cited
US5304121A
Cited
US5411550A
Cited
EP0604022A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-04-06 | 2001-10-06 | 2002-04-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-04-06 | 2005-10-06 | 2006-04-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-04-06 | 2009-10-06 | 2010-04-07 | $7700.00 | Window Closed / Lapsed |